Forty percent of radiation therapy in the United States is given with palliative intent. At the same time, palliative RT receives disproportionately low attention at national meetings, is not well studied on clinical protocols. Palliative RT remains more of an art than clinical science.

Highlights from the best scientific abstracts in thoracic radiotherapy from ASTRO 2019 will be reviewed and placed in perspective with current literature, practice guidelines and patterns of care.  Attendees should leave with a better understanding of how to incorporate these data into daily prac

There has been a recent flurry of practice-changing options for managing brain and spine metastases as a result of refinements in pathological classification of tumors, better systemic management options, improved imaging permitting precise localization of pathology and avoidance structures withi

With increasing frequency, local therapy in the form of SBRT or hypofractionated radiation is being applied to patients with oligometastatic cancers as a means of attempting to improve survival outcomes, durability of systemic therapy treatment responses, etc.  However, it is apparent that not al

The treatment paradigms for the management of rectal cancers continues to evolve with more data emerging on short course radiotherapy, total neoadjuvant therapy, and the development of non-operative management algorithms.

This course reviews the state-of-the-art treatment approaches for lung cancer.

This session will review current treatment programs for management of Hodgkin Lymphoma and non-Hodgkin Lymphoma (DLBCL, FL, MALT).

This session will help radiation oncology professionals remain current in the field of immunotherapies and radiation combined with immunotherapies.

This session will provide an overview of basic principles of breast RT and literature that supports one’s practice.  A discussion of how to identify appropriate patients for nodal RT and of advanced techniques available will follow.

Radiation oncology residents and practitioners, as well as other health professionals involved in the care of head/neck cancer patients, confront an area of oncology that is widely acknowledged as perhaps the most challenging in the field.